Norris Medicines Limited manufactures and sells pharmaceutical formulations in India. The company offers nonsterile dosage products, such as tablets, capsules, liquid orals, and copical ointments, as well as injections and medicinal formulations. Its products include antibiotics, anti-inflammatory/pain management, antiemetic, nutrition, gastro, cough/cold, skin and allergy, antimalarial, diabetic, cardiac, dental, and other medicine products. The company also provides contract and loan license manufacturing services for pharma companies. It exports its products. Norris Medicines Limited was incorporated in 1990 and is based in Ankleshwar, India.
| Current Price | ₹14.50 |
|---|---|
| Market Cap | ₹15 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | -51.8 |
| Return on Equity | 1.87% |
| 52-Week Range | ₹12.00 – ₹20.76 |
| Beta (1Y) | 0.38 |
Norris Medicines Ltd. is trading at ₹14.50, with a market capitalisation of ₹15 Cr.
Norris Medicines Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Norris Medicines Ltd. has a P/E of -51.8 and a return on equity of 1.87%.